ArticleAuthors: Pham Thi Van Anh, Nguyen Phuong Thanh; Dau Thuy Duong (2021)
A double-blind, randomized, phase II clinical trial was conducted within a 14-week follow-up including 2 weeks
of the non-drug run-in period, 8 weeks of medication, and 4 weeks of follow-up after discontinuation. The objective
of the study was to evaluate the efficacy and safety of Trang Phuc Linh Plus in irritable diarrhea syndrome patients.
Group I took Trang Phuc Linh Plus 3 tablets/time x 2 times/day for 8 weeks; Group II took placebo 3 tablets/
time x 2 times/day for 8 weeks. Patients will be re-examined, tested, and evaluated over the phone for symptom
recurrence and adverse events (AEs). This study showed that the Trang Phuc Linh Plus tablets tended to improve
sympto... 
